Adlai Nortye Ltd. (ANL)
NASDAQ·Healthcare·Biotechnology
$12.38
-6.57%
Mkt Cap $274.57M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 10, 2026 | $10.00M | $10.00M | +0.00% | -$0.10 | -$0.10 | +0.00% | — | — |
| Q4 2025 Dec 29, 2025 | $313.23K | — | — | -$0.18 | -$0.18 | +0.00% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.18 | -$0.18 | +0.00% | — | — |
| Q2 2025 Apr 30, 2025 | — | — | — | -$0.53 | -$0.22 | +58.49% | — | — |
| Q1 2025 Feb 26, 2025 | — | — | — | -$0.53 | -$0.22 | +58.49% | — | — |
| Q3 2024 Aug 8, 2024 | — | $745.00K | — | -$1.06 | -$0.53 | +50.15% | — | — |
| Q2 2024 Apr 20, 2024 | — | $2.50M | — | -$0.38 | -$0.65 | -70.52% | — | — |
| Q1 2024 Mar 31, 2024 | — | $745.00K | — | — | -$0.53 | — | — | — |
| Q3 2023 Sep 30, 2023 | $5.00M | $2.50M | -50.00% | -$0.24 | -$0.65 | -169.98% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | — | -$2.49 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.59 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.87 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$0.87 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.14 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.44 | — | — | — |